Sotera Health Company
SHC$18.86
$-0.05 (-0.26%)-0.26%
ClosedBarclays raises Sotera Health price target to $19, fueling 4.58% gain
Loading chart...
IndexN/A
Market Cap5.38B
Enterprise Value6.94B
Income$-0.01B
Sales$0.25B
EmployeesN/A
P/E19.65
P/S4.30
P/B8.27
P/C33.58
EV/EBITDA15.68
EV/SalesN/A
EPS (ttm)0.96
EarningsN/A
Gross Margin55.48%
Oper. Margin33.75%
Profit Margin6.70%
Volume3.38M
Shs Outstand0.29B
Change-0.26%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.10B | $1.05B | $1.00B | $931.48M | $818.16M | $778.33M | $746.15M |
| Cost of Revenue | $498.15M | $472.13M | $446.68M | $412.81M | $374.59M | $382.90M | $388.90M |
| Gross Profit | $602.29M | $577.16M | $557.00M | $518.67M | $443.57M | $395.43M | $357.25M |
| Gross Margin | 54.73% | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% | 47.88% |
| Operating Expenses | $304.67M | $300.47M | $308.65M | $261.94M | $237.55M | $211.83M | $276.40M |
| Operating Income | $297.63M | $276.69M | $248.35M | $256.73M | $206.02M | $183.60M | $80.85M |
| Operating Margin | 27.05% | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% | 10.84% |
| Net Income | $44.40M | $51.38M | $-233.57M | $116.88M | $-38.62M | $-20.85M | $-5.87M |
| Net Margin | 4.03% | 4.90% | -23.27% | 12.55% | -4.72% | -2.68% | -0.79% |
| EPS (Basic) | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.14 | $-0.07 | $-0.02 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $3.07B | $3.13B | $3.12B | $2.79B | $2.76B | $2.58B | $2.71B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.67B | $2.69B | $2.77B | $2.20B | $2.31B | $3.22B | $2.66B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $404.91M | $443.73M | $350.24M | $586.10M | $452.30M | $-642.57M | $44.36M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $404.91M | $443.73M | $350.24M | $586.10M | $452.30M | $-642.57M | $44.36M |
| Total Liabilities & Stockholders Equity | $3.07B | $3.13B | $3.12B | $2.79B | $2.76B | $2.58B | $2.71B |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|
| Net Income | $44.40M | $51.38M | $-233.57M | $116.88M | $-38.62M | $-20.85M | $-5.87M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $224.16M | $-147.73M | $277.96M | $281.55M | $120.58M | $149.04M | $119.56M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Sotera Health Q2 Earnings Call Highlightsmarketbeat.com Sotera Health Company (SHC) Q2 2026 Earnings Call Transcriptseekingalpha.com Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimateszacks.com Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimateszacks.com Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlookglobenewswire.com Dimensional Fund Advisors LP Buys 358,281 Shares of Sotera Health Company $SHCdefenseworld.net Bank of New York Mellon Corp Acquires 166,055 Shares of Sotera Health Company $SHCdefenseworld.net Sotera Health Announces Second-Quarter 2026 Earnings Release Dateglobenewswire.com
Show 12 more stories
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcriptseekingalpha.com Sotera Health Announces Secondary Offering of Common Stockglobenewswire.com Why Broyhill May Be Buying More Sotera Health Sharesfool.com Sotera Health Company (SHC) Q1 2026 Earnings Call Transcriptseekingalpha.com Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimateszacks.com Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimateszacks.com Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlookglobenewswire.com Sotera Health Announces Leadership Transitionglobenewswire.com Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimateszacks.com Sotera Health Company $SHC Shares Acquired by Cwm LLCdefenseworld.net
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Discover more
You may be interested in